- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01362465
Characterization of Interventricular Conduction Measurements (ICM)
September 18, 2012 updated by: Medtronic Cardiac Rhythm and Heart Failure
This study is an effort to use left ventricular (LV) lead based measurements to identify late electrical activation and avoid scar.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The aim of this study is to characterize how right ventricular (RV) to left ventricular (LV) conduction delays are altered by pacing site in patients with a cardiac resynchronization therapy (CRT) system.
The study will be performed in conjunction with a CRT implant.
Study Type
Interventional
Enrollment (Actual)
25
Phase
- Early Phase 1
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patient is greater than 18 years of age.
- The patient or the patient's legally authorized representative is willing to give informed consent.
- CRT indicated guidelines.
- Patient is receiving a Medtronic IPG or ICD.
Exclusion Criteria:
- Patients who are pregnant.
- Patient is in AF.
- Patient with 3rd degree AV block.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cardiac Resynchronization Therapy (CRT)
Implanting device to measure delays between paced chambers in heart failure patients.
|
Implanting device to measure delays between paced chambers in heart failure patients.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measure how RV to LV conduction times are altered by pacing site in patients with a CRT system.
Time Frame: 30 minutes
|
This procedure will take approximately 30 minutes prior to implant of a CRT system.
At completion of this study the patient is not followed and will be transferred to another study if enrolled in a clinical or followed as a routine implant by the center.
|
30 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Brett Atwater, MD, Durham VA
- Principal Investigator: Robert Hoyt, MD, Catholic Health Initiative Iowa Corp
- Principal Investigator: Eric E Johnson, MD, Sterns Cardiovascular Foundation
- Principal Investigator: John F Beshai, MD, University of Chicago
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2011
Primary Completion (Actual)
April 1, 2012
Study Completion (Actual)
April 1, 2012
Study Registration Dates
First Submitted
May 25, 2011
First Submitted That Met QC Criteria
May 27, 2011
First Posted (Estimate)
May 30, 2011
Study Record Updates
Last Update Posted (Estimate)
September 20, 2012
Last Update Submitted That Met QC Criteria
September 18, 2012
Last Verified
September 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TDSICM
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Indiana UniversityRecruitingCongestive Heart Failure | Congestive Heart Failure (CHF) | Congestive Heart Failure Chronic | Congestive Heart Failure(CHF)United States
-
University of Health Sciences LahoreRecruitingAcute Decompensated Heart Failure | Heart Failure, Diastolic | Heart Failure, SystolicPakistan
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
Lakeland Regional Health Systems, Inc.RecruitingHeart Failure | Heart Failure Acute | Acute Heart Failure (AHF) | Heart Failure - NYHA II - IVUnited States
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
Eli Lilly and CompanyNot yet recruitingHeart Failure | Heart Failure, Diastolic | Heart Failure, SystolicUnited States, Japan
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
Clinical Trials on Cardiac Resynchronization Therapy
-
Universitaire Ziekenhuizen KU LeuvenActive, not recruitingHeart Failure | Cardiomyopathy, Dilated | Left Ventricular Dyssynchrony | Cardiac Remodeling, VentricularBelgium, Germany, Poland, France, Switzerland, Brazil, Spain, Hungary, Latvia, Portugal, Romania
-
Larisa TereshchenkoCompletedHeart Failure | Cardiomyopathy | Left Bundle Branch BlockUnited States
-
Biotronik SE & Co. KGActive, not recruitingHeart FailureFrance, Spain, Belgium, Israel, United Kingdom, Australia, Japan, Latvia, Germany, Singapore, Italy, Switzerland, Portugal, Czechia, Taiwan, South Africa, Austria, Hungary, Slovakia, Poland
-
University Medical Center GroningenNot yet recruitingHeart Failure | Atrial Fibrillation (AF) | Cardiac PacingGermany, France, Netherlands, Italy
-
Paris Cardiovascular Research Center (Inserm U970)University Hospital, Montpellier; Groupe Hospitalier Pitie-Salpetriere; European... and other collaboratorsCompletedCongenital Heart Disease
-
Maastricht University Medical CenterMedtronicUnknownCardiac Resynchronization Therapy, Non-LBBB, QRS AreaNetherlands
-
University of LouisvilleWithdrawn
-
Medtronic Latin AmericaUnknown